Skip to content
Sign in

FBT · ARCA · ETF

First Trust Amex Biotech Index Fund (FBT) Price, Holdings & Fees

$650.66−0.51%−$3.36End-of-day price as of Oct 9, 2026

First Trust Amex Biotech Index Fund (FBT) closed at $650.66 on Oct 9, 2026, down 0.51% from the previous close of $654.02.

Share price, past year

1Y +35.95%

52-week range $473.29 – $679.44. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$650.66
Sep 30, 2026$646.19
Aug 31, 2026$654.14
Jul 31, 2026$623.65
Jun 30, 2026$606.26
May 29, 2026$625.77
Apr 30, 2026$590.31
Mar 31, 2026$562.25
Feb 27, 2026$564.69
Jan 30, 2026$550.78
Dec 31, 2025$530.40
Nov 28, 2025$497.06
Oct 31, 2025$496.16

Key statistics

Expense ratio
0.55%
as of Dec 31, 2025
Net assets
$2.8B
as of Jun 30, 2026
Holdings
32
as of Jun 30, 2026
52-week range
$473.29 – $679.44

First Trust Amex Biotech Index Fund's expense ratio is 0.55%: $55.00 a year on $10,000 invested.

Holdings

First Trust Amex Biotech Index Fund held 32 investments worth $2.81B as of Jun 30, 2026. Its largest holding was CORCEPT THERAPEUTICS INC, at 5.60% of the fund.

First Trust Amex Biotech Index Fund largest holdings by share of net assets
#Holding% of fundValue
1CORCEPT THERAPEUTICS INCCORT5.60%$157.46M
2NEOGENOMICS INCNEO5.12%$144.00M
3VERACYTE INCVCYT5.10%$143.37M
4BRUKER CORPBRKR4.32%$121.51M
5ALKERMES PLCALKS4.24%$119.20M
6ILLUMINA INCILMN3.92%$110.35M
7KRYSTAL BIOTECH INCKRYS3.87%$108.91M
8NATERA INCNTRA3.79%$106.73M
9AXSOME THERAPEUTICS INCAXSM3.71%$104.30M
10NEUROCRINE BIOSCIENCES INCNBIX3.53%$99.24M
11BIO-TECHNE CORPTECH3.43%$96.54M
12ARROWHEAD PHARMACEUTICALS INCARWR3.38%$94.97M
13BIOGEN INCBIIB3.37%$94.80M
14EXELIXIS INCEXEL3.32%$93.28M
15INCYTE CORPINCY3.18%$89.56M
16ARGENX SEARGX3.13%$88.06M
17HALOZYME THERAPEUTICS INCHALO3.11%$87.59M
18VERTEX PHARMACEUTICALS INCVRTX3.07%$86.42M
19REPLIGEN CORPRGEN3.07%$86.22M
20BIOMARIN PHARMACEUTICAL INCBMRN2.83%$79.64M
21AMGEN INCAMGN2.78%$78.30M
22BIONTECH SEBNTX2.63%$73.95M
23GENMAB A/SGMAB2.62%$73.80M
24UNITED THERAPEUTICS CORPUTHR2.56%$71.93M
25ALNYLAM PHARMACEUTICALS INCALNY2.52%$70.92M

Top 25 of 32 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

First Trust Amex Biotech Index Fund holdings by asset type
Asset type% of fund
Stocks100.01%
Cash and short-term investments0.05%
First Trust Amex Biotech Index Fund holdings by country, largest 6
Country% of fund
United States84.96%
Ireland4.24%
Netherlands3.13%
Germany2.63%
Denmark2.62%
Switzerland2.48%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, First Trust Amex Biotech Index Fund's total return was +23.35%, as reported to the SEC.

First Trust Amex Biotech Index Fund monthly total returns
MonthTotal return
Jun 30, 2026+11.20%
May 31, 2026+8.85%
Apr 30, 2026+1.91%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
First Trust Amex Biotech Index Fund
Ticker
FBT
Exchange
ARCA
Fund type
ETF
Trust
FIRST TRUST EXCHANGE-TRADED FUND
SEC series ID
S000012478
SEC CIK
0001329377
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by FIRST TRUST EXCHANGE-TRADED FUND, the trust behind First Trust Amex Biotech Index Fund, and cover all of its funds.

Frequently asked questions

What is FBT's price?

First Trust Amex Biotech Index Fund (FBT) closed at $650.66 on Oct 9, 2026, down 0.51% from the previous close of $654.02.

What is FBT's expense ratio?

First Trust Amex Biotech Index Fund's expense ratio is 0.55%: $55.00 a year on $10,000 invested.

What does FBT hold?

First Trust Amex Biotech Index Fund held 32 investments worth $2.81B as of Jun 30, 2026. Its largest holding was CORCEPT THERAPEUTICS INC, at 5.60% of the fund. Its five largest holdings were CORCEPT THERAPEUTICS INC, NEOGENOMICS INC, VERACYTE INC, BRUKER CORP, ALKERMES PLC.

How has FBT performed?

Over the 3 months to Jun 30, 2026, First Trust Amex Biotech Index Fund's total return was +23.35%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 21, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Dec 31, 2025. Prices are generated sample data for development. Data sources and disclosures